Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.

Autor: Lo Re V 3rd; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Newcomb CW; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Carbonari DM; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Mezochow AK; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hennessy S; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rentsch CT; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Park LS; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA., Tate JP; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Bräu N; James J. Peters VA Medical Center, Bronx, New York, USA.; Divisions of Infectious Diseases and Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Bhattacharya D; VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Lim JK; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Mezzacappa C; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Njei B; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Roy JA; Department of Biostatistics, Rutgers University School of Public Health, New Brunswick, New Jersey, USA., Taddei TH; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Justice AC; US Department of Veterans Affairs, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Division of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA., Torgersen J; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Dec; Vol. 33 (12), pp. e70069.

Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.

Autor: Torgersen J; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Biostatistics, Epidemiology and Informatics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Mezochow AK; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Newcomb CW; Department of Biostatistics, Epidemiology and Informatics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Carbonari DM; Department of Biostatistics, Epidemiology and Informatics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Hennessy S; Department of Biostatistics, Epidemiology and Informatics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Rentsch CT; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Park LS; Center for Population Health Sciences, Stanford University School of Medicine, Stanford, California., Tate JP; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Bräu N; Division of Infectious Diseases, Department of Medicine, James J. Peters Department of Veterans Affairs Medical Center, Bronx, New York.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Bhattacharya D; Division of Infectious Diseases, Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California.; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Lim JK; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Mezzacappa C; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Njei B; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Roy JA; Department of Biostatistics, Rutgers University School of Public Health, New Brunswick, New Jersey., Taddei TH; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Justice AC; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.; Division of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut., Lo Re V 3rd; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Biostatistics, Epidemiology and Informatics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2024 Aug 01; Vol. 184 (8), pp. 943-952.

Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort.

Autor: Mezochow AK; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Abt PL; Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA., Bittermann T; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.

Publikováno v: Transplantation [Transplantation] 2021 Aug 01; Vol. 105 (8), pp. 1800-1807.

Transfusion transmitted infections in solid organ transplantation.

Autor: Mezochow AK; U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Division of Blood and Tissue Safety and Availability, Washington, DC., Henry R, Blumberg EA, Kotton CN

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2015 Feb; Vol. 15 (2), pp. 547-54.

Indications and Outcomes with Liver Retransplantation in 2025.

Autor: Likhitsup A; Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Michigan, 3912 Taubman Center, Ann Arbor, MI, 48109-0362, USA., Fontana RJ; Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Michigan, 3912 Taubman Center, Ann Arbor, MI, 48109-0362, USA. rfontana@med.umich.edu.

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.